FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1567007592> ?p ?o ?g. }

• W1567007592 endingPage "27690" @default.
• W1567007592 startingPage "27690" @default.
• W1567007592 abstract "Cancer immunotherapy is one of the new prospective treatments for head and neck squamous cell carcinoma (HNSCC). This strategy can effectively induce anti-tumor effects. However, despite surveillance by the host immune system, tumor cells can develop and acquire malignant phenotypes, for example, invasion into stromal tissue, and metastasis to lymph nodes and distant organs. Tumors with oncogenic mutations and cellular heterogeneity actively suppress the host immune system with assistance from the tumor microenvironment, including regulatory T cells, myeloid-derived suppressor cells, and type II macrophages, leading to immunoediting and immunosuppression of the anti-tumor response in vivo . Accumulating evidence, obtained through the use of advanced immunological technology, has elucidated the interaction between tumor cells and the host immune system. Greater understanding of this interaction has given rise to new therapeutic interventions, including cancer immunotherapy. In this review, we compile recent findings from experimental and clinical studies of cancer immunotherapy and discuss whether cancer immunotherapy has been determined to be beneficial in HNSCC patients. Cancer immunotherapy, such as cancer vaccine, dendritic cell immunotherapy, and blockade of immune checkpoints, also plays a crucial role in treatments that have contributed to improving overall survival in HNSCC patients. Moreover, due to the direct improvement of tumor- or tumor microenvironment–mediated immunosuppression in HNSCC, cancer immunotherapy in combination with targeted therapy appears to be an effective and efficient therapeutic strategy. In Context The advanced genetic and immunological technologies have provided fresh insights into molecular mechanisms of tumor progression in head and neck squamous cell carcinoma (HNSCC). Sufficient effector T cell activation induces effective antitumor immune response in cancer patients. However, recent researches have shown that immune checkpoints and tumor microenvironment in which regulatory T cell and myeloid-derived suppressor cells exist repress antitumor immune response. The knowledge of cancer biology and immunology helps to develop a therapeutic theory that cancer immunotherapy induces an antitumor immune response by modulating the host immune system. In addition, identification of these immunosuppressive functions has promoted the development of the next generation of cancer immunotherapy. In this review, we summarized data from experimental models and clinical trials associated with cancer immunotherapy in several types of cancer. These data indicated that cancer immunotherapy is capable of enhancing the anti-tumor immune response in patient. Moreover, we also discussed and explored the possibility of innovative cancer immunotherapy in HNSCC. This therapeutic approach may help us to improve survival rate in patients with HNSCC. Keywords: immunosurveillance; immunosuppression; tumor microenvironment; cancer vaccine; dendritic cell; immune checkpoints; chimeric antigen receptor therapy; targeted therapy (Published: 16 June 2015) Citation: Advances in Cellular and Molecular Otolaryngology 2015, 3: 27690 - http://dx.doi.org/10.3402/acmo.v3.27690" @default.
• W1567007592 created "2016-06-24" @default.
• W1567007592 creator A5047832933 @default.
• W1567007592 creator A5087150619 @default.
• W1567007592 creator A5089186809 @default.
• W1567007592 date "2015-01-01" @default.
• W1567007592 modified "2023-09-24" @default.
• W1567007592 title "Therapeutic strategy for cancer immunotherapy in head and neck cancer" @default.
• W1567007592 cites W1979982103 @default.
• W1567007592 cites W2016292060 @default.
• W1567007592 cites W2169178790 @default.
• W1567007592 cites W2478245562 @default.
• W1567007592 doi "https://doi.org/10.3402/acmo.v3.27690" @default.
• W1567007592 hasPublicationYear "2015" @default.
• W1567007592 type Work @default.
• W1567007592 sameAs 1567007592 @default.
• W1567007592 citedByCount "4" @default.
• W1567007592 countsByYear W15670075922017 @default.
• W1567007592 countsByYear W15670075922018 @default.
• W1567007592 countsByYear W15670075922019 @default.
• W1567007592 crossrefType "journal-article" @default.
• W1567007592 hasAuthorship W1567007592A5047832933 @default.
• W1567007592 hasAuthorship W1567007592A5087150619 @default.
• W1567007592 hasAuthorship W1567007592A5089186809 @default.
• W1567007592 hasConcept C121608353 @default.
• W1567007592 hasConcept C126322002 @default.
• W1567007592 hasConcept C141071460 @default.
• W1567007592 hasConcept C143998085 @default.
• W1567007592 hasConcept C2776530083 @default.
• W1567007592 hasConcept C2777701055 @default.
• W1567007592 hasConcept C2780674031 @default.
• W1567007592 hasConcept C3018411727 @default.
• W1567007592 hasConcept C71924100 @default.
• W1567007592 hasConceptScore W1567007592C121608353 @default.
• W1567007592 hasConceptScore W1567007592C126322002 @default.
• W1567007592 hasConceptScore W1567007592C141071460 @default.
• W1567007592 hasConceptScore W1567007592C143998085 @default.
• W1567007592 hasConceptScore W1567007592C2776530083 @default.
• W1567007592 hasConceptScore W1567007592C2777701055 @default.
• W1567007592 hasConceptScore W1567007592C2780674031 @default.
• W1567007592 hasConceptScore W1567007592C3018411727 @default.
• W1567007592 hasConceptScore W1567007592C71924100 @default.
• W1567007592 hasIssue "1" @default.
• W1567007592 hasLocation W15670075921 @default.
• W1567007592 hasOpenAccess W1567007592 @default.
• W1567007592 hasPrimaryLocation W15670075921 @default.
• W1567007592 hasRelatedWork W1979477723 @default.
• W1567007592 hasRelatedWork W1993267564 @default.
• W1567007592 hasRelatedWork W2068812780 @default.
• W1567007592 hasRelatedWork W2529376761 @default.
• W1567007592 hasRelatedWork W2761903724 @default.
• W1567007592 hasRelatedWork W2949481397 @default.
• W1567007592 hasRelatedWork W3010912423 @default.
• W1567007592 hasRelatedWork W3092000636 @default.
• W1567007592 hasRelatedWork W4255835543 @default.
• W1567007592 hasRelatedWork W4308789825 @default.
• W1567007592 hasVolume "3" @default.
• W1567007592 isParatext "false" @default.
• W1567007592 isRetracted "false" @default.
• W1567007592 magId "1567007592" @default.
• W1567007592 workType "article" @default.